NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 279, Issue 6 42-6, 2000, Pages

  Stucchi, Arthur F ^a   Shofer, Scott ^a   Leeman, Susan ^a   Materne, Olivier ^a   Beer, Eve ^a   McClung, James ^a   Shebani, Khaled ^a   Moore, Finola ^a   O'Brien, Michael ^a   Becker, James M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

8 isoprostane; Neurokinin 1 receptors; Oxidative stress; Substance P; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; ISOPROSTANE; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COLITIS; DISEASE ACTIVITY; ENZYME ACTIVITY; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE INJURY; ULCERATIVE COLITIS;

EID: 0033637090     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2000.279.6.g1298     Document Type: Article

References (50)

1. Oxygen radicals in ulcerative colitis
2. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification
3. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice
4. Acquired increase in leukocyte binding by intestinal microvascular endothelium in inflammatory bowel disease
5. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
6. Depleted mucosal antioxidant defenses in inflammatory bowel disease
7. Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P
8. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: Toxins, mediators, and modulators of gene expression
9. Cardiovascular effects of CP-96345, a non-peptide blocker of tachykinin NK 1 receptors
10. Clinicopathologic study of dextran sulfate sodium experimental murine colitis
11. Biomarkers of free radical damage applications in experimental animals and in humans
12. Neuropeptide regulation of proinflammatory cytokine responses
13. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis
14. Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats
15. Dextran sulfate sodium (DSS) in rats. Clinical, structural, and ultrastructural aspects
16. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall
17. Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis
18. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: Evidence for a biological role for IL- 8 in inflammation of the colon
19. Tachykinins: Receptor to effector
20. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo
21. The neuropeptide substance P activates transcription factor NF-κB and κB-dependent gene expression in human astrocytoma cells
22. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease
23. Receptor binding sites for substance P, but not substance K. or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn's disease
24. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis
25. Receptor binding sites for substance P and substance K in the canine gastrointestinal tract and their possible role in inflammatory bowel disease
26. Beneficial effects of local or systemic lidocaine in experimental colitis
27. Neurogenic inflammation. A model for studying efferent actions of sensory nerves
28. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease
29. Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist
30. Substance P induces the expression of intercellular adhesion molecule- 1 on vascular endothelial cells and enhances neutrophil transendothelial migration
31. Substance P increases microvascular permeability via nitric oxide-mediated convective pathways
32. Substance P and related peptides in porcine cortex: Whole tissue and nuclear localization
33. Neuropeptides and inflammation: The role of substance P
34. CP-96345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin
35. Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats
36. VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P
37. Neuropeptides in inflammatory bowel disease: An update
38. Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
39. Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II
40. Effect of substance P on superoxide anion and IL- 8 production by human PMNL
41. Redox regulation of interleukin- 8 expression in MKN28 cells
42. A potent nonpeptide antagonist of the substance P (NK1) receptor
43. Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils
44. The peptide content of colonic afferents decreases following colonic inflammation
45. Lack of beneficial effect of a tachykinin receptor antagonist in experimental colitis
46. Substance P containing nerve fibers in ulcerative colitis
47. Measurement of myeloperoxidase in leukocyte-containing tissues
48. Pathogenesis of tissue injury: Role of reactive metabolites of oxygen and nitrogen
49. Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease
50. Indirect enhancement of neutrophil activity and adhesion to cultured human umbilical vein endothelial cells by isoprostanes (iPF2α-III and iPE2-III)